Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial
Go back to Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial| (NASDAQ: CMND) | Delayed: 1.00 -0.16 (13.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.16 | 52 Week High | $ | |||
| Open | $1.15 | 52 Week Low | $ | |||
| Day High | $1.15 | P/E | N/A | |||
| Day Low | $0.92 | EPS | $ | |||
| Volume | 2,068,190 | |||||
